Pediatric Nephrology Division, Pediatric Department, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Division of Nephrology, Hospital do Rim, Federal University of São Paulo, São Paulo, Brazil.
Pediatr Transplant. 2021 Mar;25(2):e13856. doi: 10.1111/petr.13856. Epub 2020 Sep 30.
AR is a major relevant and challenging topic in pediatric kidney transplantation. Our objective was to evaluate cumulative incidence of AR in pediatric kidney transplant patient, risk factors for this outcome, and impact on allograft function and survival. A retrospective cohort including pediatric patients that underwent kidney transplantation between 2011 and 2015 was designed. Risk factors for AR were tested by competing risk analysis. To estimate its impact, graft survival and difference in GFR were evaluated. Two hundred thirty patients were included. As a whole, the incidence of AR episodes was 0.16 (95% CI = 0.12-0.20) per person-year of follow-up. And cumulative incidence of AR was 23% in 1 year and 39% in 5 years. Risk factors for AR were number of MM (SHR 1.36 CI 1.14-1.63 P = .001); ISS with CSA, PRED, and AZA (SHR 2.22 CI 1.14-4.33 P = .018); DGF (SHR 2.49 CI 1.57-3.93 P < .001); CMV infection (SHR 5.52 CI 2.27-11.0 P < .001); and poor adherence (SHR 2.28 CI 1.70-4.66 P < .001). Death-censored graft survival in 1 and 5 years was 92.5% and 72.1%. Risk factors for graft loss were number of MM (HR 1.51 CI 1.07-2.13 P = .01), >12 years (HR 2.66 CI 1.07-6.59 P = .03), and PRA 1%-50% (HR 2.67 CI 1.24-5.73 P = .01). Although occurrence of AR did not influence 5-year graft survival, it negatively impacted GFR. AR was frequent in patients assessed and associated with number of MM, ISS regimen, DGF, CMV infection, and poor adherence, and had deleterious effect on GFR.
AR 是儿科肾移植的一个重要且具有挑战性的课题。我们的目的是评估儿童肾移植患者 AR 的累积发生率、该结果的危险因素以及对移植物功能和存活的影响。设计了一个包括 2011 年至 2015 年期间接受肾移植的儿科患者的回顾性队列。通过竞争风险分析测试 AR 的危险因素。为了评估其影响,评估了移植物存活率和 GFR 差异。共纳入 230 例患者。总的来说,AR 发作的发生率为 0.16(95%CI=0.12-0.20)/人年。1 年内 AR 的累积发生率为 23%,5 年内为 39%。AR 的危险因素包括 MM 数量(SHR 1.36 CI 1.14-1.63 P=0.001);ISS 与 CSA、PRED 和 AZA(SHR 2.22 CI 1.14-4.33 P=0.018);DGF(SHR 2.49 CI 1.57-3.93 P<0.001);CMV 感染(SHR 5.52 CI 2.27-11.0 P<0.001);以及依从性差(SHR 2.28 CI 1.70-4.66 P<0.001)。1 年和 5 年时死亡风险调整后的移植物存活率分别为 92.5%和 72.1%。移植物丢失的危险因素包括 MM 数量(HR 1.51 CI 1.07-2.13 P=0.01)、>12 岁(HR 2.66 CI 1.07-6.59 P=0.03)和 PRA 1%-50%(HR 2.67 CI 1.24-5.73 P=0.01)。尽管 AR 的发生并未影响 5 年移植物存活率,但它对 GFR 有负面影响。在接受评估的患者中,AR 很常见,与 MM 数量、ISS 方案、DGF、CMV 感染和依从性差有关,对 GFR 有不良影响。